Use of 1-[(2-phenylcycloprop-1-yl)carbonyl]-2-[(1,3-thiazolidin-3-yl)carbonyl]perhydroindole in the treatment of schizophrenia-associated cognitive deficits

摘要

The present invention relates to the use of 1-[(2-phenylcycloprop-1-yl)carbonyl]-2-[(1,3-thiazolidin-3-yl)carbonyl]perhydroindole and pharmaceutical compositions thereof in the treatment of and/or prophylaxis of schizophrenia, particularly in the treatment of and/or prophylaxis of cognitive disorders associated to schizophrenia.